Plegridy Injection, Solution
Product Images NDC 64406-015

Product Visual Gallery

This gallery contains 86 technical images submitted to the FDA as part of the official labeling for Plegridy (NDC 64406-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ple00 0021 01

A line graph comparing the percentage of patients with relapses over 48 weeks between Plegridy 125 mcg every 14 days and placebo groups. The X-axis represents time on study in weeks, and the Y-axis shows the percentage of patients with relapses. Plegridy group shows a lower relapse percentage (18.7%) than placebo (29.1%) at 48 weeks. Below the graph is a table indicating the number of subjects at risk at various time points for both groups.*

FDA Label Image

Ple00 0021 02

An illustration showing two prefilled pens for subcutaneous injection of peginterferon beta-1a. One pen labeled as 63 mcg Orange Pen and the other as 94 mcg Blue Pen, each designed to deliver specific doses. The pens include colored labels and injection mechanisms for patient use.*

FDA Label Image

Ple00 0021 03

An illustration showing four medical disposal and cleaning items: an alcohol wipe packet, a folded gauze pad, a peach-colored adhesive bandage, and an orange sharps container. Each item is labeled with its name below the image, depicting commonly used materials for injection site care and needle disposal.*

FDA Label Image

Ple00 0021 04

An instructional diagram labeled Figure C depicting a plegridy pen injection device. The image focuses on the pen, showing a close-up view suitable for demonstrating use or injection technique.*

FDA Label Image

Ple00 0021 05

Illustration showing a Plegridy Pen, a subcutaneous injection device for peginterferon beta-1a 125 mcg/0.5 mL. The image depicts the pen's shape and some control features, likely used for administration training or instructions in the medication kit by Biogen Inc.*

FDA Label Image

Ple00 0021 06

An instructional diagram of the Plegridy Pen, a subcutaneous injection device containing peginterferon beta-1a. The illustration labels key parts including the Green Stripes Visible, Injection Status Window, Body, Medicine Window, Medicine Visible indicator, and Cap. The diagram helps identify the components of the injection pen used for administering the medication.*

FDA Label Image

Ple00 0021 07

An instructional diagram of the Plegridy Pen, a subcutaneous injection kit containing peginterferon beta-1a 125 mcg/0.5 mL by Biogen Inc. The image highlights three features: the Injection Status Window at the top, the Expiration Date printed on the side, and the Medicine Window near the bottom of the pen. Each feature is called out with magnified views and labels.*

FDA Label Image

Ple00 0021 08

An instructional diagram showing recommended injection sites for Plegridy Pen (peginterferon beta-1a) subcutaneous administration. The front view highlights the lower abdomen and both outer thighs in blue, while the side view shows the back of the upper arm as an injection site.*

FDA Label Image

Ple00 0021 09

An instructional illustration showing a person holding a Plegridy Pen at a 90-degree angle to the thigh for subcutaneous injection. The diagram highlights proper pen orientation and injection site on the leg.*

FDA Label Image

Ple00 0021 10

An instructional illustration showing a hand holding the Plegridy Pen and pressing it down on the skin for subcutaneous injection. The diagram includes a 'Clicking Starts' text indication and a downward arrow emphasizing the injection action.*

FDA Label Image

Ple00 0021 11

An instructional illustration showing proper use of the Plegridy Pen. It depicts a person holding the pen against the skin for subcutaneous injection. An inset shows the pen with a checkmark and indicates that a clicking sound stops when the injection is complete.*

FDA Label Image

Ple00 0021 12

An instructional illustration showing a hand holding the Plegridy Pen device against the thigh. The hand is gripping the pen vertically with an upward arrow indicating the direction to pull or remove the pen from the injection site.*

FDA Label Image

Ple00 0021 13

Illustration of the Plegridy Pen showing key labeled features: Injection Status Window at the top with a green checkmark, Medicine Window in the middle displaying yellow indicators, and a Yellow Plunger at the bottom. The diagram highlights these components for user guidance on the device's status during use.*

FDA Label Image

Ple00 0021 14

An instructional diagram of the Plegridy Pen, a subcutaneous injection device for peginterferon beta-1a 125 mcg/0.5 mL. The labeled parts include the injection status window with a green checkmark, medicine window, body of the pen, needle cover indicating the needle inside, and a yellow plunger visible, illustrating key components for proper use.*

FDA Label Image

Ple00 0021 15

An instructional diagram of the Plegridy Pen, a subcutaneous injection device for peginterferon beta-1a 125 ug/.5 mL. The diagram labels key parts including the green stripes visible, injection status window, body, medicine window, medicine visible area, and cap.*

FDA Label Image

Ple00 0021 16

Illustration showing components typically included in a medication administration kit: an alcohol wipe, gauze pad, adhesive bandage, and sharps container. Each item is labeled and depicted with a simple icon.*

FDA Label Image

Ple00 0021 17

An illustration of the Plegridy Pen, a subcutaneous injection kit containing peginterferon beta-1a 125 micrograms/0.5 mL by Biogen Inc. The diagram highlights three key features: the Injection Status Window at the top, the Expiration Date panel in the middle, and the Medicine Window near the bottom of the pen.*

FDA Label Image

Ple00 0021 18

An instructional diagram showing recommended injection sites for Plegridy Pen (peginterferon beta-1a) 125 ug/.5mL subcutaneous kit. Highlighted areas include the abdomen below the waist, front thighs, and the back of the upper arm.*

FDA Label Image

Ple00 0021 19

An instructional illustration labeled as Figure E showing a hand removing a cap from a Plegridy Pen injection device by pulling it upward, preparing it for subcutaneous injection.*

FDA Label Image

Ple00 0021 20

An instructional illustration showing the proper technique for subcutaneous injection of Plegridy Pen (peginterferon beta-1a 125 ug/.5 mL). The image depicts a person holding the pen at a 90-degree angle to the skin, with a close-up inset focusing on the needle area.*

FDA Label Image

Ple00 0021 21

An instructional diagram showing a hand holding a Plegridy Pen injector device, pressing down on the thigh to initiate the injection. The illustration includes the text 'Clicking Starts' to indicate the start of the injection process, with a downward arrow emphasizing the pressing action.*

FDA Label Image

Ple00 0021 22

An instructional illustration labeled Figure H showing a person holding a Plegridy Pen steady with one hand during subcutaneous injection. The top inset depicts the pen clicking during use and indicates the clicking stops when the injection is complete.*

FDA Label Image

Ple00 0021 23

An instructional illustration showing a hand holding a Plegridy Pen and pressing it downward against the thigh, with an upward-pointing arrow indicating the motion. The figure is labeled as Figure 1 and depicts the proper positioning to prepare or inject the medication subcutaneously.*

FDA Label Image

Ple00 0021 24

Illustration of the Plegridy Pen showing the injection status window, medicine window, and yellow plunger. The diagram highlights these parts for understanding the device's injection indicators, relevant to the peginterferon beta-1a subcutaneous injection kit by Biogen Inc.*

FDA Label Image

Ple00 0021 25

An instructional diagram of the Plegridy Pen, showing labeled parts including the green checkmark, medicine window, needle cover with needle inside, injection status window, pen body, and yellow plunger visible, illustrating key features for subcutaneous administration.*

FDA Label Image

Ple00 0021 26

Illustration showing two prefilled syringes labeled by color and dosage: an orange syringe containing 63 mcg and a blue syringe containing 94 mcg, indicating different dosage options for injection.*

FDA Label Image

Ple00 0021 27

An instructional illustration labeled Figure B showing four items included in the Plegridy Pen kit by Biogen Inc.: an Alcohol Wipe, a Gauze Pad, an Adhesive Bandage, and a Sharps Container. Each item is visually represented with a corresponding label beneath it.*

FDA Label Image

Ple00 0021 28

Plegridy Pen containing peginterferon beta-1a, 125 micrograms per 0.5 mL in a prefilled subcutaneous injection pen. The pen is shown with a protective cap and an orange label around the barrel, branded by Biogen Inc., designed for human prescription use as part of a medication kit.*

FDA Label Image

Ple00 0021 29

The image shows a Plegridy Pen prefilled syringe with peginterferon beta-1a at a strength of 125 micrograms per 0.5 mL. The syringe is designed for subcutaneous injection and is labeled with a blue and white label displaying dosage details. The product is part of a kit and distributed by Biogen Inc.*

FDA Label Image

Ple00 0021 30

An illustration showing a prefilled syringe labeled as Plegridy Pen (peginterferon beta-1a) 125 mcg/.5 mL. Labeled parts include Needle Cover, Medicine in the syringe barrel, Syringe Body, and Plunger. The syringe is intended for subcutaneous injection as part of the Plegridy Pen kit by Biogen Inc.*

FDA Label Image

Ple00 0021 31

A detailed instructional illustration of a Plegridy Pen syringe labeled with areas highlighting the expiration date and medicine information on the syringe barrel. The image includes magnified circular insets that emphasize the locations of the expiration date and medicine label on the syringe.*

FDA Label Image

Ple00 0021 32

Illustration showing recommended injection sites for Plegridy Pen (peginterferon beta-1a) subcutaneous injection. It depicts green shaded areas on a person's thighs, abdomen, and back of the upper arms as suitable locations for injection. The figure provides visual guidance on proper injection site selection.*

FDA Label Image

Ple00 0021 33

An instructional illustration showing hands manipulating a Plegridy Pen for subcutaneous injection. It labels the needle cover and needle, with arrows indicating the directions for removing the needle cover and exposing the needle as part of the injection preparation process.*

FDA Label Image

Ple00 0021 34

An instructional illustration showing a hand preparing for a subcutaneous injection, associated with the Plegridy Pen kit for peginterferon beta-1a. The image demonstrates the positioning of fingers and skin pinch technique before injection.*

FDA Label Image

Ple00 0021 35

An instructional diagram showing a hand holding a Plegridy Pen at a 90-degree angle to the skin, preparing for subcutaneous injection. The image demonstrates proper needle insertion technique using the Plegridy Pen, a kit containing peginterferon beta-1a 125 mcg/0.5 mL from Biogen Inc.*

FDA Label Image

Ple00 0021 36

An instructional illustration showing a hand holding a syringe for subcutaneous injection, with the needle inserted into the skin. This image likely depicts the administration technique for Plegridy Pen (peginterferon beta-1a) subcutaneous kit.*

FDA Label Image

Ple00 0021 37

An instructional illustration showing a hand holding a Plegridy Pen injector above a patient's skin, with a green arrow pointing upward, indicating the direction for using the subcutaneous injection device.*

FDA Label Image

Ple00 0021 38

An illustration of the Plegridy Pen prefilled syringe kit showing key parts labeled: needle cover, medicine in the syringe body, and plunger. The image visually identifies the components of the peginterferon beta-1a 125 ug/.5 mL subcutaneous injection device from Biogen Inc.*

FDA Label Image

Ple00 0021 39

An instructional illustration showing four items included in the Plegridy Pen kit: an alcohol wipe, a gauze pad, an adhesive bandage, and a sharps container. Each item is clearly labeled under its image, demonstrating supplies for subcutaneous injection care and disposal.*

FDA Label Image

Ple00 0021 40

Diagram showing a single-use prefilled syringe from the Plegridy Pen kit, containing peginterferon beta-1a 125 mcg/0.5 mL for subcutaneous injection. Highlighted sections indicate the expiration date and medicine inside the syringe barrel.*

FDA Label Image

Ple00 0021 41

An instructional illustration showing preferred injection sites for subcutaneous administration of Plegridy Pen (peginterferon beta-1a 125 mcg/0.5 mL). Highlighted areas include the thighs, abdomen, and back of the upper arms, indicating where injections can be given.*

FDA Label Image

Ple00 0021 42

An instructional diagram labeled Figure F showing a hand removing the needle cover from a prefilled injection pen, exposing the needle tip. The image demonstrates how to prepare a Plegridy Pen for subcutaneous injection by removing its needle cover.*

FDA Label Image

Ple00 0021 43

Instructional illustration labeled Figure G showing a hand pinching the skin on a forearm, demonstrating the preparation for a subcutaneous injection, likely related to the use of the Plegridy Pen (peginterferon beta-1a) kit.*

FDA Label Image

Ple00 0021 44

An instructional illustration demonstrating the proper technique for subcutaneous injection using the Plegridy Pen. The image shows a hand holding the pen at a 90-degree angle, pointing downward towards the skin, with an arrow indicating insertion into the skin fold.*

FDA Label Image

Ple00 0021 45

Illustration showing the administration of a subcutaneous injection using a prefilled syringe, demonstrating the injection into the skin of the forearm. The image is associated with Plegridy Pen (peginterferon beta-1a) 125 mcg/0.5 mL dosage form kit by Biogen Inc.*

FDA Label Image

Ple00 0021 46

An instructional illustration showing a hand holding a prefilled syringe for subcutaneous injection with an arrow pointing downward toward an injection site on the skin. This is likely part of usage guidance for the Plegridy Pen (peginterferon beta-1a 125 ug/.5 mL) KIT by Biogen Inc.*

FDA Label Image

Ple00 0021 47

Image showing components of the Plegridy Pen kit, including a 23 gauge, 1¼ inch long sterile needle and a Plegridy prefilled syringe. The syringe is labeled for subcutaneous administration of peginterferon beta-1a at a strength of 125 mcg/0.5 mL by Biogen Inc.*

FDA Label Image

Ple00 0021 48

The image shows components of the Plegridy Pen injection kit by Biogen Inc. Visible items include an alcohol wipe packet, a gauze pad, an adhesive bandage, and a red sharps container for safe disposal of needles. The kit is intended for subcutaneous administration of peginterferon beta-1a 125 mcg/0.5 mL.*

FDA Label Image

Ple00 0021 49

Illustration labeled as Figure A depicting a syringe with its parts identified: plunger at the top, syringe body in the middle, cap at the bottom, and a protective rubber cover inside the cap.*

FDA Label Image

Ple00 0021 50

An illustration showing a hand holding a Plegridy Pen, a subcutaneous injection device for peginterferon beta-1a 125 mcg/0.5 mL. The image demonstrates how to hold the pen for administration, part of the Plegridy Pen kit by Biogen Inc.*

FDA Label Image

Ple00 0021 51

An instructional illustration showing hands preparing a prefilled syringe pen for injection. The syringe is held upright, with a red safety tab being removed from the device, demonstrating part of the process for using the Plegridy Pen (peginterferon beta-1a) subcutaneous injection kit.*

FDA Label Image

Ple00 0021 52

Instructional diagram labeled 'Figure D' showing how to attach the black cap of a Plegridy Pen syringe with a glass syringe tip. The image highlights the removal or positioning of the cap with a red curved arrow indicating movement away from the glass syringe tip.*

FDA Label Image

Ple00 0021 53

An instructional illustration demonstrating use of the Plegridy Pen prefilled syringe. It shows two hands holding the syringe: one hand holding the body and the other pressing down on the plunger with a red arrow indicating downward movement. The image guides proper subcutaneous injection technique for peginterferon beta-1a 125 mcg/0.5 mL.*

FDA Label Image

Ple00 0021 54

An instructional illustration showing two hands manipulating a prefilled syringe pen. The top hand is gripping the pen's cap, and a red circular arrow indicates a twisting motion to remove or secure the cap. This image likely demonstrates part of the preparation or injection process for the Plegridy Pen, containing peginterferon beta-1a for subcutaneous use.*

FDA Label Image

Ple00 0021 55

An illustration showing the front and side views of a human lower leg and foot. The image highlights a rectangular injection site area on the upper front and upper side of the calf, indicating where a subcutaneous injection might be administered, consistent with instructions for the Plegridy Pen (peginterferon beta-1a) subcutaneous injection kit.*

FDA Label Image

Ple00 0021 56

An instructional diagram showing two hands assembling a Pen device by attaching a needle with a green hub to the main body of the Plegridy Pen, indicating a step in preparation for use with a red arrow pointing right to guide the assembly process.*

FDA Label Image

Ple00 0021 57

An instructional illustration showing a hand holding a syringe needle at a 90-degree angle above the skin on a person's arm, demonstrating the proper technique for subcutaneous injection. A downward red arrow indicates the direction of insertion.*

FDA Label Image

Ple00 0021 58

An instructional illustration showing a hand pressing the plunger of a subcutaneous injection pen into the skin of a person's arm. The image is labeled to indicate the plunger, which is being pushed downward for injection.*

FDA Label Image

Ple00 0021 59

An instructional illustration showing a hand holding a Plegridy Pen vertically at a 90-degree angle above a bent knee, indicating the correct method for subcutaneous injection using the pen.*

FDA Label Image

Ple00 0021 60

An instructional illustration showing components of the Plegridy Pen kit including a yellow clip marked 1/2, a purple clip marked 3/4, a 23 gauge 1¼ inch long sterile needle, and the Plegridy prefilled syringe. Each item is labeled to assist with proper identification and use.*

FDA Label Image

Ple00 0021 61

An instructional illustration showing components of a Plegridy Pen kit, including an alcohol wipe, a gauze pad, an adhesive bandage, and a sharps container for safe disposal of used needles.*

FDA Label Image

Ple00 0021 62

An instructional diagram of the Plegridy Pen subcutaneous injection kit showing a labeled syringe with a plunger on top, a protective rubber cover at the bottom, and a cap attached to the protective cover.*

FDA Label Image

Ple00 0021 63

Illustration showing a hand holding the Plegridy Pen, a prefilled subcutaneous injection device for peginterferon beta-1a 125 mcg/0.5 mL. The image demonstrates proper grip positioning for administering the injection, part of the Plegridy Pen kit by Biogen Inc.*

FDA Label Image

Ple00 0021 64

Illustration showing the preparation of the Plegridy Pen injection. One hand is holding the Plegridy Pen vial while the other hand removes the protective cap. This diagram demonstrates part of the subcutaneous injection process for peginterferon beta-1a.*

FDA Label Image

Ple00 0021 65

Illustration from the Plegridy Pen medication guide showing how to remove the glass syringe tip cover. The diagram highlights the glass syringe tip and features a red arrow indicating the removal direction of the tip cover from the pen needle assembly.*

FDA Label Image

Ple00 0021 66

An instructional illustration showing hands holding a prefilled syringe with a needle cap being pulled off downward, indicating preparation of the Plegridy Pen for subcutaneous injection.*

FDA Label Image

Ple00 0021 67

An instructional illustration showing hands preparing a syringe for injection. The image focuses on the technique of handling the syringe and removing or attaching a needle cap, related to the administration of a subcutaneous injection for Plegridy Pen (peginterferon beta-1a) 125 mcg/.5 mL kit by Biogen Inc.*

FDA Label Image

Ple00 0021 68

An illustration showing two filled Plegridy Pen devices for subcutaneous injection: one yellow pen labeled as 1/2 dose (Dose 1) and one purple pen labeled as 3/4 dose (Dose 2). The image demonstrates the different dose amounts available for administration.*

FDA Label Image

Ple00 0021 69

An instructional diagram labeled Figure H showing a close-up side view of the collar component of a pre-filled pen injector. The pen is likely part of the Plegridy Pen kit for subcutaneous administration of peginterferon beta-1a.*

FDA Label Image

Ple00 0021 70

An illustration showing two vertical graduated syringes side by side, one marked with smaller volume increments and the other labeled 1/2. The illustration highlights volume measurement as might be relevant to dosing or injection guidance.*

FDA Label Image

Ple00 0021 71

An illustration showing a pink Plegridy Pen injector device with visible volume markings along the side. The pen appears to have a protective cap on one end and is designed for subcutaneous injection of peginterferon beta-1a.*

FDA Label Image

Ple00 0021 72

Illustration showing a close-up view of the Plegridy Pen identifying a part labeled as the 'Door.' This diagram is likely from the pen's instructional materials indicating a functional component for user reference.*

FDA Label Image

Ple00 0021 73

An instructional illustration depicting a Plegridy Pen syringe being inserted or engaged into a yellow holder or device component. The image shows the pen syringe positioned horizontally above the holder, with red arrows pointing downward to indicate the direction of insertion or placement, likely as part of the pen's assembly or preparation for use.*

FDA Label Image

Ple00 0021 74

An instructional illustration showing the Plegridy Pen, a prefilled syringe for subcutaneous injection of peginterferon beta-1a 125 micrograms/0.5 mL. The image highlights components of the pen with red arrows, likely indicating operational or safety features as part of the user guidance for this Biogen Inc. drug delivery kit.*

FDA Label Image

Ple00 0021 75

Instructional diagram showing a person holding a Plegridy Pen for subcutaneous injection, preparing to use the prefilled pen device with labeled direction indicators. The image demonstrates proper handling technique for administering peginterferon beta-1a injection.*

FDA Label Image

Ple00 0021 76

Illustration of a prefilled Plegridy Pen syringe containing peginterferon beta-1a 125 micrograms/0.5 mL for subcutaneous injection. The syringe features a yellow plastic body with measurement markings and a protective cap covering the needle, designed for patient self-administration.*

FDA Label Image

Ple00 0021 77

An anatomical illustration showing the front and side views of a lower leg with a red rectangular highlight on the front thigh area, indicating a subcutaneous injection site for the Plegridy Pen kit containing peginterferon beta-1a 125 mcg/0.5 mL.*

FDA Label Image

Ple00 0021 78

An instructional diagram showing a hand holding a Plegridy Pen and another hand removing the needle cap. A red arrow indicates the direction for removing the cap from the needle, illustrating preparation steps for subcutaneous injection of peginterferon beta-1a using the Plegridy Pen kit.*

FDA Label Image

Ple00 0021 79

An instructional illustration showing a hand holding a Plegridy Pen autoinjector, labeled 125, about to inject subcutaneously into the forearm of a person. The image indicates the injection direction with a downward red arrow.*

FDA Label Image

Ple00 0021 80

An instructional illustration showing a close-up of hands holding a Plegridy Pen injection device, demonstrating the technique for administering the subcutaneous injection using the pen.*

FDA Label Image

Ple00 0021 81

An instructional illustration showing a hand holding a Plegridy Pen subcutaneous injection device positioned above a forearm. A red arrow points downward, indicating the direction for administering the injection using the pen device.*

FDA Label Image

Ple00 0021 82

Label for Plegridy Pen (peginterferon beta-1a) Injection Starter Pack by Biogen Inc., showing single-dose prefilled autoinjectors with strengths of 63 mcg/0.5 mL and 94 mcg/0.5 mL for subcutaneous use only. Includes instructions to dispense with enclosed Medication Guide.*

FDA Label Image

Ple00 0021 83

Label for Plegridy Pen (peginterferon beta-1a) Injection, 125 mcg/0.5 mL, a subcutaneous human prescription drug kit by Biogen Inc. The label states the contents include 2 single-dose prefilled autoinjectors and directions for use every 14 days with an enclosed Medication Guide. The product is marked Rx only.*

FDA Label Image

Ple00 0021 84

Box label for Plegridy (peginterferon beta-1a) Injection Starter Pack featuring two single-dose prefilled syringes with strengths 63 mcg/0.5 mL and 94 mcg/0.5 mL. The product is for subcutaneous use only, labeled for prescription use, and manufactured by Biogen Inc.*

FDA Label Image

Ple00 0021 85

Packaging label for Plegridy (peginterferon beta-1a) Injection, 125 mcg/0.5 mL, for subcutaneous use only. The label states the product contains 2 single-dose prefilled syringes and is for prescription use only. It includes Biogen's logo and a reminder to dispense with the enclosed medication guide.*

FDA Label Image

Ple00 0021 86

Packaging label for Plegridy Pen, containing peginterferon beta-1a injection at a strength of 125 mcg/0.5 mL. The label indicates the product is for intramuscular use only, supplied as a kit with 2 single-dose prefilled syringes and 2 needles. Manufactured by Biogen Inc, the label emphasizes new route of administration and includes dispensing instructions and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.